Figure

Conifer Point Pharmaceuticals

has been acquired by

Lodo Therapeutics!

Visit www.lodotherapeutics.com for more information

Conifer Point Consulting continues!

We apply advanced computational tools to help drug researchers design and improve early stage compounds addressing challenging targets.

Conifer Point Consulting helps drug discovery researchers create successful drug candidates by combining experimental and computational techniques to design and improve early stage compounds. We also offer industry-standard computational chemistry services, at an affordable price, to small companies so they may screen—or synthesize— fewer, more targeted compounds to get reliable, well-behaved, and successful hits. Our technology, and discovery process also help generate non-obvious ideas for compound progression.

Our expert consultants and advanced computational tools and services help drug researchers design and improve early stage compounds addressing challenging targets. We can also help create novel compounds with strengthened intellectual property (IP) protection, enhance the IP estate around existing compounds and avoid obstructive patents, and generate fast-follower compounds for early market entry.

Conifer Point Consulting has developed and supports Boltzmann Maps, a web application for drug design that empowers early stage drug discovery. Boltzmann Maps provides drug researchers with tools to design and prioritize small molecules in pre-clinical drug discovery. Click here for more information.